AnaptysBio, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported net loss was USD 26.41 million compared to USD 32.54 million a year ago. Basic loss per share from continuing operations was USD 0.93 compared to USD 1.18 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.47 USD | -0.51% | -1.09% | +18.91% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.91% | 699M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- AnaptysBio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022